MedPage Today on MSN
Compounded Imiquimod Shows Promise for Ocular Surface Cancers
A compounded form of imiquimod, a topical immune response modifier, showed promise as a treatment for ocular surface ...
Until the healthcare industry modernizes the referral process, it can't truly say it's delivering on the promise of connected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results